Wen‐Jia Zuo

<i>GATA3</i> mutations define a unique subtype of luminal‐like breast cancer with improved survival

Yizhou Jiang, Ke‐Da Yu, Wen‐Jia Zuo et al. · Cancer · 2014 · 74 citations

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial

Yin Liu, Xiu-Zhi Zhu, Yi Xiao et al. · Cell Research · 2023 · 63 citations · Full text

Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement

Yin Liu, Min He, Wen‐Jia Zuo et al. · Frontiers in Oncology · 2021 · 45 citations · Full text

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma

Jun Zhu, Hao Wen, Xingzhu Ju et al. · PLoS ONE · 2017 · 39 citations · Full text

Immunology, Pathology, Ovarian Carcinosarcoma +16

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival

Ying Zhang, Ya-Jie Ji, Jianwei Li et al. · Breast Cancer Research and Treatment · 2018 · 29 citations

Hormonal Contraceptive, Breast Oncology, Medicine +11